source
- Capricor sues Nippon Shinyaku over delayed Duchenne drug rollout and pricing formula flawCapricor Therapeutics has filed a lawsuit in New Jersey alleging that Nippon Shinyaku and its US subsidiary NS Pharma have failed to execute agreed upon marketing plans for the company's Duchenne m…
- FDA proposes stripping gender references from regulations, prompting research concernsThe U.S. Food and Drug Administration has issued a proposal to eliminate references to gender in its regulatory language. The change is intended to modernize the rules but has drawn attention from…